Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).
暂无分享,去创建一个
A. Astudillo | R. Marcos-Gragera | A. Roca-Barceló | A. García-Velasco | R. Fuentes-Raspall | L. Vilardell | M. Puigdemont | M. Solans | S. Del Barco | R. Comas | Mª Carme Carmona-Garcia | Aina Roca-Barceló
[1] B. Rasmussen,et al. The Danish Neuro-Oncology Registry: establishment, completeness and validity , 2016, BMC Research Notes.
[2] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[3] O. Visser,et al. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. , 2015, European journal of cancer.
[4] R. Henriksson,et al. Brain tumors in Sweden: Data from a population-based registry 1999–2012 , 2015, Acta oncologica.
[5] R. Marcos-Gragera,et al. Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era. , 2014, Cancer epidemiology.
[6] A. Olschowski,et al. Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry , 2013, British Journal of Cancer.
[7] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[8] M. Sant,et al. Survival of European patients with central nervous system tumors , 2012, International journal of cancer.
[9] Damien C Weber,et al. Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.
[10] Janez Stare,et al. On Estimation in Relative Survival , 2012, Biometrics.
[11] G. Kantor,et al. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. , 2011, Neuro-oncology.
[12] M. Geraci,et al. Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. , 2010, European journal of cancer.
[13] J. Birch,et al. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. , 2009, Neuro-oncology.
[14] C. Saurina,et al. Accurately estimating breast cancer survival in Spain: cross-matching local cancer registries with the National Death Index. , 2009, Revista panamericana de salud publica = Pan American journal of public health.
[15] H. Heinzl,et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry , 2009, Journal of Neuro-Oncology.
[16] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[17] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[18] Timothy C Ryken,et al. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.
[19] F. Langmark,et al. Trends in Incidence of Brain and Central Nervous System Tumors in Norway, 1970–1999 , 2004, Neuroepidemiology.
[20] F. Davis,et al. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States , 1999, Cancer Causes & Control.
[21] P. Trott,et al. International Classification of Diseases for Oncology , 1977 .
[22] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. , 2016, Neuro-oncology.
[23] A. Niemierko,et al. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. , 2016, Journal of neurosurgery.
[24] P. Wen,et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review , 2014 .
[25] C. Kruchko,et al. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends. , 2013, Journal of registry management.
[26] R. Marcos-Gragera,et al. Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994–2005 , 2010, Journal of Neuro-Oncology.